Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Current Assets (2016 - 2022)

Edesa Biotech's Current Assets history spans 10 years, with the latest figure at $15.2 million for Q2 2022.

  • For Q2 2022, Current Assets rose 5.9% year-over-year to $15.2 million; the TTM value through Jun 2022 reached $15.2 million, up 5.9%, while the annual FY2021 figure was $12.1 million, 49.19% up from the prior year.
  • Current Assets for Q2 2022 was $15.2 million at Edesa Biotech, down from $18.0 million in the prior quarter.
  • Across five years, Current Assets topped out at $21.4 million in Q1 2021 and bottomed at $3.4 million in Q4 2018.
  • The 5-year median for Current Assets is $8.1 million (2019), against an average of $10.0 million.
  • The largest annual shift saw Current Assets crashed 54.32% in 2018 before it soared 188.42% in 2021.
  • A 5-year view of Current Assets shows it stood at $3.4 million in 2018, then soared by 42.36% to $4.8 million in 2019, then skyrocketed by 58.84% to $7.7 million in 2020, then increased by 29.01% to $9.9 million in 2021, then soared by 53.46% to $15.2 million in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Current Assets are $15.2 million (Q2 2022), $18.0 million (Q1 2022), and $9.9 million (Q4 2021).